Registry and Biosample Repository
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 89 |
| Updated: | 4/21/2016 |
| Start Date: | June 2008 |
| Contact: | Jay Dorsey, MD, PhD |
| Email: | PennCancerTrials@emergingmed.com |
| Phone: | 855-216-0098 |
The goal of this study is two-fold: to establish a tissue banking respository (defined as
blood, urine, soft tissue, tumor specimen, and normal tissue from areas surrounding tumor
specimens), and to prospectively assess health related quality of life (QOL) over time in
patients with a pathologically confirmed diagnosis of neoplasia receiving radiotherapy or
photodynamic therapy (PDT)
blood, urine, soft tissue, tumor specimen, and normal tissue from areas surrounding tumor
specimens), and to prospectively assess health related quality of life (QOL) over time in
patients with a pathologically confirmed diagnosis of neoplasia receiving radiotherapy or
photodynamic therapy (PDT)
Inclusion Criteria:
- Anyone age 18 and above with a cancer diagnosis
- Able to sign consent
We found this trial at
1
site
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-6065
Principal Investigator: Jay Dorsey, MD, PhD
Phone: 855-216-0098
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
Click here to add this to my saved trials
